ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2023

A multicenter study on efficacy of dual-target neoadjuvant therapy for HER2-positive breast cancer and a consistent analysis of efficacy evaluation of neoadjuvant therapy by Miller-Payne and RCB pathological evaluation systems (CSBrS-026).

Hongyu Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.